Skip to content

Clinical trials

Phase 3 Acute Coronary Syndrome trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Phase: Phase 3 Country / region: Canada Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20063
20073
20083
20095
20105
20111
20141
20161
20182
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated4
Recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Sanofi3
DalCor Pharmaceuticals2
Eli Lilly and Company2
GlaxoSmithKline2
Mark Eisenberg2
Amarin Pharma Inc.1
Anthera Pharmaceuticals1
Bristol-Myers Squibb1
CSL Behring1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome30
Myocardial Infarction7
Cardiovascular Diseases6
Heart Diseases5
Coronary Artery Disease4
Non-ST Elevated Myocardial Infarction4
ST Elevation Myocardial Infarction4
Angina, Unstable3
Coronary Disease3
Myocardial Ischemia3

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.